These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21312050)

  • 21. Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.
    Curtis JR; Martin C; Saag KG; Patkar NM; Kramer J; Shatin D; Allison J; Braun MM
    Arthritis Rheum; 2007 Mar; 57(2):343-6. PubMed ID: 17330283
    [No Abstract]   [Full Text] [Related]  

  • 22. Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial.
    Genovese MC; Tena CP; Covarrubias A; Leon G; Mysler E; Keiserman M; Valente R; Nash P; Simon-Campos JA; Box J; Legerton CW; Nasonov E; Durez P; Delaet I; Teng J; Alten R
    J Rheumatol; 2014 Apr; 41(4):629-39. PubMed ID: 24584926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate and oral ulceration.
    Deeming GM; Collingwood J; Pemberton MN
    Br Dent J; 2005 Jan; 198(2):83-5. PubMed ID: 15702101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacotherapy of patients with (early) rheumatoid arthritis].
    van Rijthoven AW
    Ned Tijdschr Geneeskd; 2000 Mar; 144(11):539. PubMed ID: 10735141
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methotrexate for therapy of rheumatoid arthritis].
    Suzuki Y; Wakabayashi T; Jackson K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():498-502. PubMed ID: 15799406
    [No Abstract]   [Full Text] [Related]  

  • 26. What dose of folic acid to use with methotrexate in rheumatoid arthritis?
    Bramley D
    Drug Ther Bull; 2021 Jul; 59(7):103-106. PubMed ID: 34162667
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methotrexate therapy for rheumatism and collagen diseases].
    Osone Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):330-6. PubMed ID: 16646163
    [No Abstract]   [Full Text] [Related]  

  • 28. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan.
    Chiu YM; Lang HC; Lin HY; Yang MT; Fang CH; Yang YW; Schabert VF; Tang B
    Int J Rheum Dis; 2014 Dec; 17 Suppl 3():9-19. PubMed ID: 25496045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing patterns in the use of slow acting antirheumatic drugs for the treatment of rheumatoid arthritis.
    Horsfall MW; Shaw JP; Highton J; Cranch PJ
    N Z Med J; 1998 Jun; 111(1067):200-3. PubMed ID: 9673632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical characteristics related to methotrexate-induced pancytopenia.
    Ohosone Y; Okano Y; Kameda H; Hama N; Mimori T; Akizuki M; Ikeda Y
    Clin Rheumatol; 1997 May; 16(3):321-3. PubMed ID: 9184276
    [No Abstract]   [Full Text] [Related]  

  • 33. Safe prescribing of methotrexate for rheumatoid arthritis.
    Kirkham BW
    Med J Aust; 1995 Sep; 163(5):278. PubMed ID: 7565224
    [No Abstract]   [Full Text] [Related]  

  • 34. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
    Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methotrexate in rheumatology: a therapeutic revolution].
    Kaye O; Ribbens C; Hauwaert C; Malaise MG
    Rev Med Liege; 1995 Nov; 50(11):453-7. PubMed ID: 8532990
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of breathlessness.
    Shafei R; Goalby R; Hutchinson J
    BMJ; 2015 Jul; 351():h3515. PubMed ID: 26185147
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of chronic polyarthritis with methotrexate 1994--a review].
    Rau R
    Z Rheumatol; 1994; 53(4):199-229. PubMed ID: 7975933
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tofacitinib versus methotrexate in rheumatoid arthritis.
    Lee EB; Fleischmann R; Hall S; Wilkinson B; Bradley JD; Gruben D; Koncz T; Krishnaswami S; Wallenstein GV; Zang C; Zwillich SH; van Vollenhoven RF;
    N Engl J Med; 2014 Jun; 370(25):2377-86. PubMed ID: 24941177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methotrexate: advantages of subcutaneous administration].
    Krüger K
    Z Rheumatol; 2008 Jul; 67(4):332-3. PubMed ID: 18443809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.